Challenging the recessive paradigm of Mahvash disease: heterozygous phenotypes from a novel splice-site variant. [PDF]
Bugallo FM, de GG, Prieto-Morín C.
europepmc +1 more source
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter +20 more
wiley +1 more source
Impact of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors on Post-liver Transplant New-onset Major Adverse Cardiovascular Events, Graft Failure, Renal Outcome, and Mortality. [PDF]
Kosako Yost KC +11 more
europepmc +1 more source
Summary Introduction Surgery in patients with diabetes mellitus is associated with increased morbidity and mortality compared with those who do not have diabetes mellitus. This is likely multifactorial and could be attributed to organisational issues; dysglycaemia; hospital‐acquired diabetic ketoacidosis; errors with insulin prescribing and ...
Nicholas A. Levy +19 more
wiley +1 more source
Effects of GLP-1 Agonists on Patients with Hidradenitis Suppurativa: A Systematic Review. [PDF]
Caliezi A +3 more
europepmc +1 more source
Defective HNF1A hinders GLI3 processing favoring duodenal versus pancreatic fate, thus leading to intestinal elongation in vivo. [PDF]
Unger L +11 more
europepmc +1 more source
GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity. [PDF]
Lee JJ, Bajgain P, Lightner AL.
europepmc +1 more source
Progressive HNF1A-MODY pathophysiology revealed by a translational mouse model. [PDF]
Louvet I +15 more
europepmc +1 more source
Incretin and Glucagon Signalling in MASLD and MASH: Integrating Metabolic Pathways With Disease Progression. [PDF]
Tsakiridis EE, Steinberg GR.
europepmc +1 more source

